ALT
Price
$2.17
Change
-$0.06 (-2.69%)
Updated
Oct 22 closing price
Capitalization
422.1M
14 days until earnings call
Intraday BUY SELL Signals
OGEN
Price
$0.41
Change
-$0.00 (-0.00%)
Updated
Oct 22, 02:35 PM (EDT)
Capitalization
1.86M
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALT vs OGEN

ALT vs OGEN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALT vs. OGEN commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and OGEN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ALT with price predictions
Oct 22, 2026

ALT's Indicator enters downward trend

The Aroon Indicator for ALT entered a downward trend on October 22, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 281 similar instances where the Aroon Indicator formed such a pattern. In 252 of the 281 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALT as a result. In 77 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

ALT moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ALT crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALT advanced for three days, in 203 of 256 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

ALT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. ALT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.890) is normal, around the industry mean (2.973). P/E Ratio (-2.855) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (1609.233) settles around the average of (128.121) among similar stocks. ALT's P/S Ratio (10000.000) is very high in comparison to the industry average of (438.009).

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for OGEN with price predictions
Oct 22, 2026

Momentum Indicator for OGEN turns negative, indicating new downward trend

OGEN saw its Momentum Indicator move below the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 86 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for OGEN turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 39 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGEN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for OGEN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where OGEN advanced for three days, in 155 of 201 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

OGEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.507) is normal, around the industry mean (2.973). P/E Ratio (0.421) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. OGEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ALT vs OGEN: Fundamental Ratings
ALT
OGEN
OUTLOOK RATING
1..100
5553
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
8484
P/E GROWTH RATING
1..100
181
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGEN's Valuation (65) in the Biotechnology industry is in the same range as ALT (94) in the Miscellaneous Commercial Services industry. This means that OGEN’s stock grew similarly to ALT’s over the last 12 months.

OGEN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that OGEN’s stock grew similarly to ALT’s over the last 12 months.

ALT's SMR Rating (96) in the Miscellaneous Commercial Services industry is in the same range as OGEN (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to OGEN’s over the last 12 months.

ALT's Price Growth Rating (84) in the Miscellaneous Commercial Services industry is in the same range as OGEN (84) in the Biotechnology industry. This means that ALT’s stock grew similarly to OGEN’s over the last 12 months.

OGEN's P/E Growth Rating (1) in the Biotechnology industry is in the same range as ALT (18) in the Miscellaneous Commercial Services industry. This means that OGEN’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTOGEN
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 23 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ALT: $2.23 vs. OGEN: $0.41)
Brand notoriety: ALT and OGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 115% vs. OGEN: 72%
Market capitalization -- ALT: $422.1M vs. OGEN: $1.86M
ALT [@Biotechnology] is valued at $422.1M. OGEN’s [@Biotechnology] market capitalization is $1.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 1 FA rating(s) are green while OGEN’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 1 green, 4 red.
  • OGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, OGEN is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while OGEN’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 5 bearish.
  • OGEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OGEN is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а -3.46% price change this week, while OGEN (@Biotechnology) price change was -7.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

ALT is expected to report earnings on Nov 05, 2026.

OGEN is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ALT
Daily Signal:
Gain/Loss:
OGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with OGEN. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-2.69%
OGEN - ALT
54%
Loosely correlated
-1.82%
INDP - ALT
45%
Loosely correlated
-5.38%
FLNA - ALT
44%
Loosely correlated
-0.79%
DNLI - ALT
44%
Loosely correlated
-0.11%
RCKT - ALT
43%
Loosely correlated
+5.00%
More

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with CDIO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then CDIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-1.82%
CDIO - OGEN
38%
Loosely correlated
-4.52%
MGX - OGEN
36%
Loosely correlated
-1.52%
UNCY - OGEN
34%
Loosely correlated
+1.81%
GOVX - OGEN
32%
Poorly correlated
-8.40%
SRPT - OGEN
30%
Poorly correlated
-2.05%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ILPT7.160.24
+3.54%
Industrial Logistics Properties Trust
SCI83.692.53
+3.12%
Service Corp
ANDE65.10-0.60
-0.91%
Andersons
INSG4.19-0.22
-4.99%
Inseego Corp
PPBT1.02-0.13
-11.30%
Purple Biotech Ltd.